ID
45656
Description
Principal Investigator: Jeffrey S. Weber, MD, PhD, Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida, USA MeSH: Melanoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001241 This study contains sequence data from 15 patients with stage IV melanoma, including the whole genome sequence of 15 metastatic tumors and corresponding normal blood samples from 13 cases, and targeted capture sequence of four synchronous metastatic samples from two additional cases. These data provide a comprehensive survey of the clonal architecture and associated driver mutations in metastatic melanoma.
Lien
Mots-clés
Versions (1)
- 21/03/2023 21/03/2023 - Simon Heim
Détendeur de droits
Jeffrey S. Weber, MD, PhD, Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, Florida, USA
Téléchargé le
21 mars 2023
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs001241 Clonal Architectures and Driver Mutations in Metastatic Melanomas
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, age, and gender of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, sample ID, and sample use variable obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Subject ID, age, and gender of participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
- Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample obtained from participants with melanoma and involved in the "Clonal Architectures and Driver Mutations in Metastatic Melanomas" project.
C0680251 (UMLS CUI [1,2])
C1706256 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1321872 (UMLS CUI [1,4])